Cellular Therapy for Extreme Preterm Infants at Risk of Developing Bronchopulmonary Dysplasia
Clinical trial NCT04255147 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04255147
- Sponsor
- Ottawa Hospital Research Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-17
- Primary completion
- 2023-11-06
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.